Covered recipient · General Payments record
CANDICE L COLEMAN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2024
$2,123.80
- Reported across 85 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $625.63 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $183.80 | 7 |
| Gilead Sciences, Inc. | $161.75 | 3 |
| Acerta Pharma LLC | $125.00 | 1 |
| ABBVIE INC. | $67.89 | 3 |
| Abbott Laboratories | $45.71 | 2 |
| PFIZER INC. | $20.91 | 1 |
| Corcept Therapeutics | $20.57 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $20.63 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124828773 | CMS |
| Abbott Laboratories | $25.08 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124828775 | CMS |
| ABBVIE INC. | $20.64 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106936067 | CMS |
| ABBVIE INC. | $20.21 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106936069 | CMS |
| ABBVIE INC. | $27.04 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106936071 | CMS |
| AstraZeneca Pharmaceuticals LP | $125.00 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104688824 | CMS |
| Corcept Therapeutics | $20.57 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117770036 | CMS |
| Gilead Sciences, Inc. | $20.62 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133663020 | CMS |
| Gilead Sciences, Inc. | $125.00 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133663022 | CMS |
| Gilead Sciences, Inc. | $16.13 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133663024 | CMS |
| Novo Nordisk Inc | $3.57 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100330638 | CMS |
| Novo Nordisk Inc | $16.56 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100304733 | CMS |
| Novo Nordisk Inc | $124.26 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100653287 | CMS |
| Novo Nordisk Inc | $9.69 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100232736 | CMS |
| Novo Nordisk Inc | $6.82 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100534815 | CMS |
| Novo Nordisk Inc | $5.27 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100373761 | CMS |
| Novo Nordisk Inc | $17.63 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100313581 | CMS |
| PFIZER INC. | $20.91 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131518641 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.